Does Mounjaro Affect Migraine with Aura?

Is migraine with aura a reason not to take Mounjaro?

Not automatically. The Mounjaro Summary of Product Characteristics — the prescriber's reference document, held on the Electronic Medicines Compendium — does not list migraine with aura among the contraindications. So a blanket "you can't take this" is not what the evidence says. What it does say is that prescribers should build a full clinical picture before approving treatment, and a history of aura is a detail that belongs in that picture.

Why does it matter? Migraine with aura carries a modestly elevated cardiovascular risk in some groups, particularly women who also smoke or use combined hormonal contraception. That context doesn't make tirzepatide off-limits, but it is the kind of thing a prescriber weighs alongside your BMI, your other conditions, and your current medicines. At the Mounjaro overview page you'll find more on how the drug works and who it is generally licensed for in the UK.

The short answer for most people with well-controlled migraine with aura: discuss it honestly at consultation. A real clinician reads your answers the same day (not a scoring algorithm) so give them the full picture and let that assessment do its job.

Could tirzepatide make migraines worse, at least initially?

Possibly, for some people, and mainly through indirect routes rather than a direct pharmacological effect on migraine mechanisms. The most common side effects of tirzepatide, as documented on the NHS tirzepatide medicines page, are gastrointestinal: nausea, vomiting, and changes in bowel habit, particularly in the first weeks and after each dose step up.

Both nausea and vomiting-driven dehydration are well-recognised migraine triggers. If your attacks are already sensitive to either, the early weeks of treatment could be a difficult window. That's not a reason to avoid treatment, but it is a reason to plan around it: stay hydrated, eat regularly despite reduced appetite, and make sure your prescriber knows your migraine pattern before your first pen arrives.

Headache itself is also listed as a common side effect of tirzepatide in a general sense. Distinguishing a medication-related headache from a prodrome or a post-aura headache takes a bit of attention in the first month. Keeping a brief symptom diary during the titration period gives your prescriber something concrete to work with at the first review. Our guide to Mounjaro and migraines more broadly goes into that side-effect profile in more detail.

What should I watch for, and when should I contact someone urgently?

New or significantly changed visual symptoms are the main thing to flag without delay. Aura that looks different from your usual pattern, lasts longer, or arrives without the headache you'd normally expect should be reported to your prescriber or GP the same day. Sudden visual changes can occasionally signal something unrelated to migraine, and tirzepatide does not alter that rule.

Separately, the January 2026 MHRA Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as a known but infrequent serious risk: severe stomach pain that radiates to the back, with or without vomiting, warrants urgent medical attention. People with migraine sometimes dismiss abdominal pain as a migraine symptom; it's worth knowing this presentation is different in character. You can report any suspected side effect, including changes to your migraine pattern, via the MHRA Yellow Card scheme.

If you're worried about something between consultations and you're a patient of ours, our aftercare team is available seven days a week. Reach them via the contact page.

Does migraine with aura affect how you'd approach contraception on tirzepatide?

This is an important practical question. UK guidance advises that women taking tirzepatide who rely on oral contraceptives should use an additional non-oral method (such as condoms) for the first four weeks of treatment and for four weeks after every dose increase. Slowed gastric emptying can reduce pill absorption enough to matter. This guidance applies regardless of migraine history, but it is especially relevant here because many neurologists and GPs already recommend that women with migraine with aura avoid combined oestrogen-containing contraception due to stroke risk considerations. If you're currently on a combined pill specifically chosen because of your migraine history, that's a conversation to have with your GP or prescriber before starting tirzepatide, not after.

Curious about the cost of private treatment while you're thinking it through? The treatment and pricing page sets out what's included in a single transparent fee, consultation, prescription, and next-working-day delivery, no subscription. A full clinical review of your history, migraine included, is part of the process from day one, and our clinical team brings that level of oversight to every case. Patients sometimes arrive with broader lifestyle questions too, from whether using cocaine alongside Mounjaro carries additional risks to how to handle eating out at restaurants while on the medication, and our clinicians are used to addressing all of it without judgement. If you'd like a deeper look at the relationship between this treatment and headache conditions before committing, our dedicated page on how Mounjaro interacts with migraines covers the evidence in full. For those based in or around Voi, our Mounjaro service page covers how to access treatment in that area.